Nutriband Inc. – NASDAQ:NTRB

Founder-led company

Nutriband stock price today

$6.22
+2.36
+61.56%
Financial Health
0
1
2
3
4
5
6
7
8
9

Nutriband stock price monthly change

-41.22%
month

Nutriband stock price quarterly change

-41.22%
quarter

Nutriband stock price yearly change

+29.02%
year

Nutriband key metrics

Market Cap
45.31M
Enterprise value
21.39M
P/E
-4.01
EV/Sales
10.46
EV/EBITDA
-3.46
Price/Sales
11.79
Price/Book
2.47
PEG ratio
0.04
EPS
-0.77
Revenue
2.01M
EBITDA
-5.46M
Income
-6.36M
Revenue Q/Q
-14.34%
Revenue Y/Y
-2.96%
Profit margin
-321.56%
Oper. margin
-321.27%
Gross margin
35.44%
EBIT margin
-321.27%
EBITDA margin
-270.8%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Nutriband stock price history

Nutriband stock forecast

Nutriband financial statements

Nutriband Inc. (NASDAQ:NTRB): Profit margin
Jul 2023 655.92K -829.17K -126.41%
Oct 2023 427.84K -1.75M -411.36%
Jan 2024 524.61K -1.88M -358.54%
Apr 2024 408.53K -1.89M -464.61%
Nutriband Inc. (NASDAQ:NTRB): Analyst Estimates
2026 4M 0
2027 4.75M 0
  • Analysts Price target

  • Financials & Ratios estimates

0%
Yield TTM
Nutriband Inc. (NASDAQ:NTRB): Payout ratio
Payout ratio 0%
Nutriband Inc. (NASDAQ:NTRB): Dividend Yield
2016
2017
2019
2020
2022 0.66%
Nutriband Inc. (NASDAQ:NTRB): Debt to assets
Jul 2023 9872628 2.98M 30.2%
Oct 2023 8523076 2.81M 32.99%
Jan 2024 7517154 1.07M 14.35%
Apr 2024 15154480 1.79M 11.82%
Nutriband Inc. (NASDAQ:NTRB): Cash Flow
Jul 2023 -995.13K 0 2.05M
Oct 2023 -1.06M 0 -4.96K
Jan 2024 -718.24K -49.13K -5.00K
Apr 2024 -833.92K -6.19K 8.69M

Nutriband alternative data

Nutriband Inc. (NASDAQ:NTRB): Employee count
Aug 2023 13
Sep 2023 13
Oct 2023 13
Nov 2023 13
Dec 2023 13
Jan 2024 13
Feb 2024 13
Mar 2024 13
Apr 2024 13
May 2024 13
Jun 2024 13
Jul 2024 13

Nutriband other data

0.48% -1.75%
of NTRB is owned by hedge funds
40.89K -133.74K
shares is hold by hedge funds

Nutriband Inc. (NASDAQ:NTRB): Insider trades (number of shares)
Period Buy Sel
Feb 2022 6000 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
GOODMAN GERALD officer: Chief Financial Officer
Stock Warrant 87,500 $1.93 $168,875
Purchase
MELNIK SERGUEI director, officer.. Common Stock, par value $0.001 per share 5,000 $4.03 $20,150
Purchase
MELNIK SERGUEI director, officer.. Common Stock, par value $0.001 per share 500 $4.03 $2,015
Purchase
MELNIK SERGUEI director, officer.. Common Stock, par value $0.001 per share 500 $4.03 $2,015
Insider Compensation
Mr. Gareth Sheridan (1990) Founder, Chief Executive Officer & Director $60,000
Mr. Michael Myer (1984) Pres of Pocono Pharmaceutical & Director
$40,600
Mr. Serguei Melnik (1974) Founder, Pres & Director $26,000
Friday, 27 December 2024
globenewswire.com
Wednesday, 4 December 2024
globenewswire.com
Wednesday, 27 November 2024
globenewswire.com
Thursday, 31 October 2024
accesswire.com
Thursday, 17 October 2024
accesswire.com
Wednesday, 2 October 2024
accesswire.com
Tuesday, 24 September 2024
accesswire.com
Friday, 20 September 2024
accesswire.com
Monday, 16 September 2024
accesswire.com
Wednesday, 4 September 2024
accesswire.com
Friday, 19 July 2024
accesswire.com
Monday, 15 July 2024
accesswire.com
Thursday, 20 June 2024
accesswire.com
Monday, 3 June 2024
accesswire.com
Thursday, 16 May 2024
accesswire.com
Friday, 10 May 2024
accesswire.com
Tuesday, 23 April 2024
accesswire.com
Friday, 19 April 2024
accesswire.com
Monday, 25 March 2024
accesswire.com
Monday, 4 March 2024
accesswire.com
Monday, 29 January 2024
Accesswire
Wednesday, 19 April 2023
Accesswire
Friday, 20 May 2022
Accesswire
  • What's the price of Nutriband stock today?

    One share of Nutriband stock can currently be purchased for approximately $6.22.

  • When is Nutriband's next earnings date?

    Nutriband Inc. is estimated to report earnings on Monday, 1 Sep 2025.

  • Does Nutriband pay dividends?

    No, Nutriband does not pay dividends.

  • How much money does Nutriband make?

    Nutriband has a market capitalization of 45.31M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 46.63% to 2.09M US dollars.

  • What is Nutriband's stock symbol?

    Nutriband Inc. is traded on the NASDAQ under the ticker symbol "NTRB".

  • What is Nutriband's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Nutriband?

    Shares of Nutriband can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Nutriband's key executives?

    Nutriband's management team includes the following people:

    • Mr. Gareth Sheridan Founder, Chief Executive Officer & Director(age: 35, pay: $60,000)
    • Mr. Michael Myer Pres of Pocono Pharmaceutical & Director(age: 41, pay: $40,600)
    • Mr. Serguei Melnik Founder, Pres & Director(age: 51, pay: $26,000)
  • Is Nutriband founder-led company?

    Yes, Nutriband is a company led by its founders Mr. Gareth Sheridan and Mr. Serguei Melnik.

  • How many employees does Nutriband have?

    As Jul 2024, Nutriband employs 13 workers.

  • When Nutriband went public?

    Nutriband Inc. is publicly traded company for more then 3 years since IPO on 1 Oct 2021.

  • What is Nutriband's official website?

    The official website for Nutriband is nutriband.com.

  • Where are Nutriband's headquarters?

    Nutriband is headquartered at 121 South Orange Avenue, Orlando, FL.

  • How can i contact Nutriband?

    Nutriband's mailing address is 121 South Orange Avenue, Orlando, FL and company can be reached via phone at +40 73776695.

Nutriband company profile:

Nutriband Inc.

nutriband.com
Exchange:

NASDAQ

Full time employees:

13

Industry:

Biotechnology

Sector:

Healthcare

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

121 South Orange Avenue
Orlando, FL 32801

CIK: 0001676047
ISIN: US67092M2089
CUSIP: 67092M208